drugset / Trial / NCT00186446

Treatment of Nicotine Dependence and Acute Depression

NCT00186446

Phase 4 Completed 20 enrolled Stanford University GlaxoSmithKline · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and feasibility of concurrent treatment of nicotine dependence (cigarette smoking) and acute depression. Participants who meet DSM-IV criteria for both nicotine dependence and acute major depression will be given pharmacological treatment for both disorders at the same time, along with a brief behavioral intervention for smoking cessation.

Timeline

Start
2004-06
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule